{
    "clinical_study": {
        "@rank": "47041", 
        "arm_group": [
            {
                "arm_group_label": "HBOT", 
                "arm_group_type": "Experimental", 
                "description": "Group will be treated with HBOT for 60 treatments in 3 months."
            }, 
            {
                "arm_group_label": "Control/Crossover", 
                "arm_group_type": "Other", 
                "description": "Control for 3 months without treatment, and then HBOT for 60 treatments in 3 months."
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the current study is to evaluate, in a prospective cross-over, randomized study,\n      the effect of hyperbaric oxygen therapy (HBOT) on patients with chronic neurological\n      deficits and cognitive impairment after anterior skull base meningioma tumor removal."
        }, 
        "brief_title": "Hyperbaric Oxygen Therapy Can Improve Neurological State Post Meningioma Removal Surgery", 
        "condition": [
            "Intracranial Meningioma", 
            "Neurologic Deficits"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Meningioma", 
                "Neurologic Manifestations"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Post intracranial meningioma removal surgery 3-12 months prior to the inclusion in\n             the study.\n\n          -  All patients have to have persistent cognitive or neurological complaints regarding\n             without noticeable improvement during the last month prior to their enrolment.\n\n          -  Age 18 years or older.\n\n        Exclusion Criteria:\n\n          -  Dynamic neurologic/cognitive improvement or worsening during the past month;\n\n               -  Evidence of dynamic cognitive/neurological improvement in the last month.\n\n               -  Previous brain radiotherapy and/or radiosurgery.\n\n               -  Steroids dependence\n\n               -  Seizures 1 month previous to inclusion\n\n               -  Had been treated with HBOT for any other reason 1 month prior to inclusion;\n\n               -  Have any other indication for HBOT;\n\n               -  Chest pathology incompatible with pressure changes;\n\n               -  Inner ear disease;\n\n               -  Patients suffering from claustrophobia;\n\n               -  Inability to sign written informed consent;\n\n               -  Smoking patients will not be allowed to smoke during the study and if they would\n                  not comply with this demand they will be excluded."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "62", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 10, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02084927", 
            "org_study_id": "37/14"
        }, 
        "intervention": {
            "arm_group_label": [
                "HBOT", 
                "Control/Crossover"
            ], 
            "description": "HBOT of 2 ATA for 90 minutes, for 60 treatments", 
            "intervention_name": "HBOT", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 10, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Zerifin,", 
                    "country": "Israel", 
                    "zip": "70300"
                }, 
                "name": "Assaf-Harofeh Medical Center"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "official_title": "Hyperbaric Oxygen Therapy Can Improve Neurological State Post Meningioma Removal Surgery -Randomized Prospective Trial", 
        "overall_contact": {
            "email": "amir.had@gmail.com", 
            "last_name": "Amir Hadanny, MD", 
            "phone": "972544707381"
        }, 
        "overall_official": {
            "affiliation": "Assaf-Harofeh Medical Center", 
            "last_name": "Shai Efrati, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "January 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Cognitive function will be assessed using the one-hour Mindstreams Computerized Cognitive Test Battery at baseline, 3 months and 6 months to intervention.", 
            "measure": "Neurocognitive functions", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02084927"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Assaf-Harofeh Medical Center", 
            "investigator_full_name": "Assaf Harofeh MC", 
            "investigator_title": "Shai Efrati", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Quality of live will be evaluated by the EQ-5D questionnaire at baseline , 3 months and 6 months to intervention.", 
            "measure": "Quality of Life", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "source": "Assaf-Harofeh Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Assaf-Harofeh Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}